Document is current
Any future updates will be listed below
-
Authors
Nadin, Tom
Wallis, Dinny
Holroyd, Christopher R.
D’Angelo, Stefania
Walker-Bone, Karen
Edwards, Christopher J.
-
Funding
Funding for this research was provided by:
Partly supported by an unrestricted research grant from AbbVie (-)
- License Information
-
More Information
Article History
Received: 3 July 2019
Accepted: 27 March 2020
First Online: 6 April 2020
Ethics approval and consent to participate
: The study was approved by the West of Scotland Research Ethics Service. Written informed consent was obtained from the subjects.
: Written consent to publish findings from this study was obtained from the subjects.
: TN: None declared; DW: Grant/research support from: Janssen, MSD, Pfizer, AbbVie, Novartis; CH: Consultant for AbbVie, Novartis, Napp and UCB. Speakers bureau: AbbVie, BMS, Chugai, Janssen, Lilly, Novartis, UCB.KW-B: None declared, CJE: Consultant for: AbbVie, Pfizer, Lilly, Celltrion, Mundipharma, Samsung, Anthera, UCB, Celgene, Roche, BMS, Jansen, Novartis and UCB., Speakers bureau: AbbVie, Pfizer, Lilly, Celltrion, Mundipharma, Samsung, Anthera, UCB, Celgene, Roche, BMS, Jansen, Novartis and UCB.
